- Home
- CAC vs PRCT Comparison
CAC vs PRCT Comparison
Compare CAC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAC | PRCT |
|---|---|---|
| Founded | 1875 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.2M | 1.0B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CAC | PRCT |
|---|---|---|
| Price | $56.86 | $20.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $47.00 | $35.44 |
| AVG Volume (30 Days) | 75.8K | ★ 1.5M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ 6.08 | 1.71 |
| EPS | ★ 2.64 | N/A |
| Revenue | $41,739,000.00 | ★ $308,054,000.00 |
| Revenue This Year | $19.15 | $31.34 |
| Revenue Next Year | $6.05 | $24.52 |
| P/E Ratio | $21.43 | ★ N/A |
| Revenue Growth | 16.96 | ★ 37.22 |
| 52 Week Low | $35.00 | $16.67 |
| 52 Week High | $60.59 | $42.43 |
Technical Indicators
Market Signals| Indicator | CAC | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 48.82 |
| Support Level | $52.34 | $19.64 |
| Resistance Level | $60.07 | $29.27 |
| Average True Range (ATR) | 1.56 | 1.02 |
| MACD | -0.36 | 0.02 |
| Stochastic Oscillator | 49.80 | 2.08 |
Price Performance
Historical ComparisonAbout CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.